AfternsAfterns
Up or down this time?Nov 5 scheduled
0%0%

···

Moderna Inc. (MRNA) earnings date & stock reaction

Moderna Inc. · Healthcare

Moderna Inc. earnings date & time

Next earningsThu, November 5 around 8:00 AM ET, before the openscheduled

Schedule

Korea time (KST)
Thu, November 5
Reporting pattern
12 of last 12 before open
Typical move
±7.3% · 12-report avg

What the market expects

Consensus EPS

$-1.35Coming in above this counts as a beat

Year-ago quarter
$-0.51→-164.7%
Full earnings calendarFrom an earnings calendar

Price after the latest report

Reported July 31, 2026how the stock moved around it
Next-day move
-5.3%
After 5 days
-7.0%
Price around earnings
Around this report
Sector peer Alnylam Pharmaceuticals Inc. -28.3% next day (7/30)A same-industry peer, Alnylam Pharmaceuticals Inc., reported within the 10 days before this one (1d earlier). How the market took it (next-day move -28.3%) is the best read on the sector mood. A beat that still fell means the bar was high, so this stock may face similar pressure.

Moderna Inc. (MRNA) rose the day after earnings in 5 of its last 12 reports (42%), moving ±7.3% on average. It has fallen despite beating the consensus estimate 6 times.

Up next day
5/12
42%
Fell despite growth
5/12
Good earnings ignored
Price when beating
-0.8%
avg over 10 beats
Price when missing
-1.6%
avg over 2 misses
Avg earnings move
±7.3%
typical swing on earnings
Biggest single move
-21.0%
'24.8 · largest reaction
🔑What actually moves this stock?

Even when EPS beat expectations, the stock fell 6 of the last 10 times. The number alone doesn't move it.

What really matters here
Not earnings: trial results and FDA approvals drive the stock
In finance terms: Trial/FDA events
What to watch next report

Track trial readouts and FDA dates, not the earnings number.

The real bar for this stock

Beating estimates isn't enough. Here's where the real surprise started.

Beat consensus 10 of 12 times
Median beat +20.7%. 6 of those beats still fell the next day.
Reports that rose beat by +76.6% (median). Reports that fell beat by just +20.7%
Roughly +76.6% was the bar this stock had to clear.

How this stock reacts to earnings

Traits seen across its recent earnings reactions

Tends to slide in the week before earnings
Fell beforehand 10 of last 12 · avg -4.8%
Even strong results barely move the stock
Up the next day 4 of 10 beats (40%)
Reaction is erratic and hard to predict
Avg -0.8% on a beat, -1.6% on a miss
Tends to keep drifting the same way for days
Day-one direction continued · 67% of last 12
vs Healthcare sector avg (155 peers)
This
-0.9%
Sector
+0.5%
Avg next-day reaction

Earnings number vs guidance: which drives it?

How often the beat/miss matched the actual price move

This stock reacts more to guidance & expectations than the reported number
Moved opposite to results 7 of last 12 times (58%)
6xBeat but fell
Even a beat sells off if guidance disappoints
1xMissed but rose
Even a miss rebounds if guidance reassures
Fell despite growth5/12

6/10 beats fell next day · watches Trial/FDA events

Next-day reaction
  • Jun 2026 report-5.3%
  • Mar 2026 report-1.2%
  • Dec 2025 report+5.3%
  • Sep 2025 report+3.3%
  • Jun 2025 report-6.6%
  • Mar 2025 report-5.3%

Earnings timeline · bars = next-day move, ▲▼ = beat/miss

Apr–Jun 2026 results
Reported 2026-07-31
Next-day move
-5.3%
After 5 days -7.0%
EPS consensus -$2.06 → -$1.97 ▲ +4.3% beatRev $142M → $145M +2% YoY
Beat by +4.3% but stock -5.3%
Price around earnings
Around this report
Sector peer Alnylam Pharmaceuticals Inc. -28.3% next day (7/30)A same-industry peer, Alnylam Pharmaceuticals Inc., reported within the 10 days before this one (1d earlier). How the market took it (next-day move -28.3%) is the best read on the sector mood. A beat that still fell means the bar was high, so this stock may face similar pressure.

Earnings trend · last 12 quarters

EPS$-1.97YoY +8%
'23.11'26.7
Revenue$0.1BYoY +2%
'23.11'26.7

Earnings history and price reaction

Moderna Inc. across its last 12 earnings reports: EPS versus consensus, the move on the earnings day, and the cumulative move five trading days later.
Quarter endedReported (ET)vs market expectation (consensus)Earnings dayAfter 5 days
6/20262026-07-31+4.3%-5.3%-7.0%
3/20262026-05-01+12.4%-1.2%+5.7%
12/20252026-02-13+18.9%+5.3%+24.3%
9/20252025-11-06+76.6%+3.3%+13.4%
6/20252025-08-01+28.3%-6.6%-10.0%
3/20252025-05-01+20.7%-5.3%-15.7%

12 reports, quarters ending 9/2023 to 6/2026. The earnings-day move is the first trading day that reflects the report; the five-day figure is the cumulative move from that point.

Frequently asked questions

When is the next Moderna Inc. earnings date?

The next Moderna Inc. (MRNA) earnings report is expected Thu, November 5 around 8:00 AM ET, before the open. It comes from an earnings calendar and may not be a company-confirmed date; it updates automatically if it changes.

What is the consensus EPS forecast for Moderna Inc.'s next earnings?

Analysts expect EPS of about $-1.35 for Moderna Inc. (MRNA). Coming in above that counts as a beat, below it a miss — though a beat does not guarantee the stock rises.

Does Moderna Inc. (MRNA) stock usually go up after earnings?

Over the last 12 earnings reports, the stock rose on 5 of them (42%). The average move on earnings day was ±7.3%.

Does Moderna Inc. react more to the earnings numbers or to guidance?

In 7 of the last 12 reports (58%), the stock moved the opposite way from whether it beat or missed the forecast. A high share means guidance and expectations drive the move more than the reported numbers.

Can Moderna Inc. stock fall even when earnings are good?

Yes. In 5 of the last 12 reports, Moderna Inc. fell on the earnings day despite growing EPS. Expectations already priced in, or guidance, can matter more than the reported numbers.

Does Moderna Inc. stock keep moving after the earnings day?

Over the last 12 reports, the move continued in the same direction for the following five trading days 67% of the time. This tendency is known as post-earnings announcement drift.